Establishment of COVID-19 diagnostic method by new PCR device using a small amount of saliva as a sample

Establishment of SARS-CoV-2 rapid screening test for COVID-19 diagnosis using small amount of saliva as a sample and examination of usefulness of mobile type qPCR device (PCR1100) - Establishment of COVID-19 diagnostic method using a new mobile qPCR device using a small amount of saliva as a sample

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044435

Enrollment

Registered

2021-06-07

Start date

2021-06-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Among patients who are hospitalized or scheduled to be hospitalized under a definitive diagnosis of COVID-19, adult men and women who have no interest and have consented to this study at their own free will after receiving the explanation of this study. In addition, all of the following criteria shall be met. (1) A definitive diagnosis has been obtained by the current qPCR test. (2) Patients with symptoms that allow them to wash their mouth.

Exclusion criteria

Exclusion criteria: Those who fall under any of the following are excluded. (1) Persons who cannot obtain informed consent by themselves. (2) Persons who cannot wash their mouth by themselves.

Design outcomes

Primary

Measure	Time frame
Similar results can be obtained with the new mobile-type qPCR device used in this study using samples from COVID-19-positive patients.	—

Countries

Japan

Contacts

Public ContactReiko Tokuyama-Toda

Tsurumi University Department of Oral Medicine and Stomatology

tokuyama-r@tsurumi-u.ac.jp045-580-1001

Outcome results